Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare...
Biotech and Pharmaceuticals
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Jacob Van Naarden is busy. In addition to running Eli Lilly's oncology business, he's now responsible for finding the drugmaker's next...
Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug...
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Thomas Fuller | Lightrocket | Getty ImagesReplimune plans to resubmit its melanoma drug to the Food and Drug Administration for...
CDC says American tests positive for Ebola in Africa, risk in the U.S. remains low
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March...
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen plans to advance an experimental drug for Alzheimer's disease to late-stage...
Marty Makary resigns as FDA commissioner following industry and White House backlash
Food and Drug Administration Commissioner Marty Makary speaks during an announcement at the Department of Health and Human Services on...
Rare disease families find roadmap to drug development at bootcamps
Developing a new drug can cost a billion dollars and take more than a decade. That makes investing in new...
Wearable patches: How Barrière is trying to disrupt the supplement industry
The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health and wellness.Along...
CVS blows past estimates, hikes outlook as insurance business outperforms
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026.Jeenah Moon...
Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark,...
FDA commissioner defends agency's drug approval decisions after wave of backlash
U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday after months of pressure...
Danco Laboratories seeks Supreme Court stay of ruling pausing mail-order access to abortion drugs
An abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on...
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary...
AstraZeneca stock falls after FDA panel votes against new cancer drug
Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug. An advisory panel for...
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook by...
FDA fast-tracks psychedelic drug research following Trump executive order
FILE PHOTO: Psilocybin or "magic mushrooms" are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA)...
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.Lilly...
Trump nominates Erica Schwartz as CDC director
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March...
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't...
